Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 530163 | NSE Symbol : | ISIN : INE817B01025 | Industry : Pharmaceuticals - Indian - Formulations |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
10-Feb-2025	14-Feb-2025	Quarterly Results	KERALA AYURVEDA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve the Integrated unaudited Standalone and Consolidated Financial Results for the quarter ended 31st December 2024. Outcome of Board Meeting held on 14th Feb 2025 Outcome of Board Meeting held on 14th Feb 2025 (As Per BSE Announcement Dated on 14.02.2025) Integrated Filing (Financial) for the quarter ended 31st December, 2024. The company has already filed the Integrated Financial results for the quarter ended 31 st December, 2024 under the results Tab on 14th Feb 2025 (As per BSE Announcement Dated on 03/03/2025)
04-Dec-2024	09-Dec-2024	Preferential Issue	Preferential Issue of shares & Inter-alia, to consider the following matters: i. To consider a proposal for issuance of equity shares by way of a preferential allotment to investors (other than promoter & promoter group) in accordance with the provisions of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, the Companies Act, 2013, as amended, subject to such regulatory/ statutory approvals as may be required. ii. To consider convening an extra-ordinary general meeting to seek approval of the shareholders in respect of the following: a) Proposal for fund raising as provided above; and b) Regularization of Directors (Mr. Samir Dhawan, Additional Director designated as NonExecutive Independent Director, Mr. Kshiti Ranjan Das, Additional Director designated The Board Meeting to be held on 09/12/2024 Stands Cancelled. With reference to our earlier intimation dated December 04, 2024 we hereby inform that the Board Meeting scheduled to be held on December 9, 2024 has been postponed due to unavoidable reasons. The Company will inform the revised date of Board Meeting, as per the prescribed timelines under Regulation 29 of the Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, in due course. (As per BSE Announcement Dated on 05/12/2024)
11-Nov-2024	14-Nov-2024	Quarterly Results	KERALA AYURVEDA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve the quarterly results for the quarter ended 30th Sept 2024. Outcome of Board (As per BSE Announcement dated on 14/11/2024)
07-Aug-2024	14-Aug-2024	Quarterly Results	KERALA AYURVEDA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June 2024. Outcome of the Board meeting held on 14th August 24 Financial Results for the quarter ended 30th June 2024 (As per BSE Announcement Dated on 14/08/2024)
22-May-2024	29-May-2024	Accounts	KERALA AYURVEDA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve the audited financial results for the quarter and year ended 31st March 2024 Audited Financial Statements for the quarter and year ended 31st March 2024 outcome of Board (As Per BSE Announcement Dated on 29.05.2024)
06-Feb-2024	14-Feb-2024	Quarterly Results	KERALA AYURVEDA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve the unaudited financial results for the quarter ended 31st December 2023. Outcome of the Board held on 14th Feb 24 alongwith Standalone and Consolidated financials for the quarter ended 31st December, 23 and Press Release (As Per BSE Announcement Dated on: 14/02/2024)
21-Nov-2023	24-Nov-2023	Preferential Issue	KERALA AYURVEDA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/11/2023 inter alia to consider and approve Fund raising by way of Preferential Allotment of equity shares of Kerala Ayurveda Limited. Outcome of the Board meeting held on 24/11/2023 (As Per BSE Announcement Dated on 24/11/2023)
07-Nov-2023	14-Nov-2023	Quarterly Results	KERALA AYURVEDA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30th September 2023. Unaudited Financial Results for the Quarter and Half Year ended 30th Sept 23 (As per BSE Announcement Dated on 14/11/2023)
03-Oct-2023	03-Oct-2023	Change in Other Executives	Appointment of CEO
28-Aug-2023	31-Aug-2023	Preferential Issue	KERALA AYURVEDA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/08/2023 inter alia to consider and approve Fund raising by way of preferential allotment of equity shares of Kerala Ayurveda Ltd. The Board has approved the Agenda items subject to the approval of Shareholders'' at AGM. Revised outcome of the Board meeting held on 31.8.2023 (As Per BSE Announcement dated on 31.08.2023)
02-Aug-2023	10-Aug-2023	Quarterly Results	KERALA AYURVEDA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2023 inter alia to consider and approve the unaudited financial results for the quarter ended 30th June 2023 Standalone and consolidated unaudited results for the quarter ended 30th June 2023 (As Per BSE Announcement dated on 10.08.2023)
12-Jul-2023	12-Jul-2023	Acquisitions	Announcement under regulation 30(LODR)
22-May-2023	30-May-2023	Accounts	KERALA AYURVEDA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve the Audited Standalone and Consolidated Financial Results for the quarter and year ended 31st March 2023. Copy of Audited Standalone and Consolidated Financial Results for the Quarter and Year ended 31/3/2023 is attached. (As Per BSE Announcement dated on 30.05.2023)
08-May-2023	11-May-2023	Preferential Issue	KERALA AYURVEDA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/05/2023 ,inter alia, to consider and approve i. To approve adoption of new articles of association of the Company; ii. To consider a proposal for issuance of equity shares by way of a preferential allotment to investors (other than promoter & promoter group) in accordance with the provisions of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, the Companies Act, 2013, as amended, subject to such regulatory/ statutory approvals as may be required.; iii. To consider convening an extra-ordinary general meeting / postal ballot process to seek approval of the shareholders in respect of the aforesaid proposal of fund raising, as required. Outcome of the Board Meeting held on 11th May 2023 in accordance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') This is with reference to the above-mentioned subject, we, Kerala Ayurveda Limited (the 'Company') would like to inform you that the Board of Directors of the Company at its meeting held today i.e. 11th May 2023 has, inter-alia, considered and approved the following: 1. Approved the adoption of new set of Articles of Association ('AOA') of the Company containing regulations in conformity with the Companies Act, 2013 subject to the approval of the shareholders. Further, the brief details of adoption of the new AOA as required under Regulation 30 read with Part A of the Schedule III of the SEBI Listing Regulations are annexed herewith as Annexure-A. (As Per BSE Announcement Dated on 11/05/2023)
06-Feb-2023	14-Feb-2023	Quarterly Results	KERALA AYURVEDA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 inter alia to consider and approve the standalone and consolidated quarterly results for the quarter ended 31st December 2022. Outcome of the Board meeting held on 14th Feb 2023 to consider the Financial results for the quarter ended 31st December, 2022 Appointment of company secretary and compliance officer (As per BSE Announcement Dated on 14/02/2023)

1 2

LOGIN HERE

Kerala Ayurveda Ltd

Board Meeting